|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| C07K 16/00 | (2013.01) | ||
| A61M 5/178 | (2006.01) | ||
| C07K2317/10 | (2013.01) | ||
| C07K 1/00 | (2006.01) | ||
| C07K2317/21 | (2013.01) | ||
| C07K 16/00 | (2006.01) | ||
| C07K2317/94 | (2013.01) | ||
| A61K 39/39591 | (2013.01) | ||
| A61P 19/02 | (2018.01) | ||
| A61P 19/08 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/16 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 37/02 | (2018.01) |
| (11) | Number of the document | 3763384 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20186174.7 |
| Date of filing the European patent application | 2015-12-03 | |
| (97) | Date of publication of the European application | 2021-01-13 |
| (45) | Date of publication and mention of the grant of the patent | 2024-08-28 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 14196069 | 2014-12-03 | EP |
| (72) |
Pedrussio, Renzo , CH
Styger, Regula , CH
|
| (73) |
CSL Behring AG ,
Wankdorfstrasse 10, 3014 Bern,
CH
|
| (54) | PHARMACEUTICAL PRODUCT WITH INCREASED STABILITY COMPRISING IMMUNOGLOBULINS |
| PHARMACEUTICAL PRODUCT WITH INCREASED STABILITY COMPRISING IMMUNOGLOBULINS |